(Q33952000)

30 July 2017

1 reference

title

The pharmacology of headache. (English)

1 reference

30 July 2017

1 reference

Goadsby PJ

1

1 reference

30 July 2017

1 December 2000

1 reference

30 July 2017

17

1 reference

inferred from page(s)

published in

Progress in Neurobiology

1 reference

30 July 2017

62

1 reference

30 July 2017

509-525

1 reference

30 July 2017

5

1 reference

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Plasma Serotonin in Migraine and Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Subcutaneous sumatriptan during the migraine aura

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Naratriptan: biological profile in animal models relevant to migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Effect of Sumatriptan, a Selective 5-HT1-like Receptor Agonist, on Pial Vessel Diameter in Anaesthetised Cats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Rizatriptan has central antinociceptive effects against durally evoked responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Responses of feline trigeminal spinal tract nucleus neurons to stimulation of the middle meningeal artery and sagittal sinus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Interactions of GR127935, a 5-HT(1B/D) receptor ligand, with functional 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

5-HT1-like receptor mediated changes in porcine carotid haemodynamics: are 5-HT1D receptors involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMA

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Facial flushing after thermocoagulation of the Gasserian ganglion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The 5-HT7 receptor: orphan found

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

1 reference

7 January 2021

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Altered oesophageal motility following the administration of the 5-HT1 agonist, sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

5-HT1C receptor activation: a key step in the initiation of migraine?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Autoradiographic localization of 5-HT1E and 5-HT1F binding sites in rat brain: effect of serotonergic lesioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Serotonin 5-HT1B/1D Receptor Agonists in Migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

1 reference

7 January 2021

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Neuropeptide changes in a case of chronic paroxysmal hemicrania--evidence for trigemino-parasympathetic activation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Cutaneous sensory stimulation leading to facial flushing and release of calcitonin gene-related peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Diagnosis and management of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Isolation and expression of a complementary DNA that confers multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

An ionophoretic study of the responses of rat caudal trigeminal nucleus neurones to non-noxious mechanical sensory stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Migraine and concomitant symptoms among 8167 adult twin pairs.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Is chest pain after sumatriptan oesophageal in origin?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Preclinical Studies on the Anti-Migraine Drug, Sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Serotonin and migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The mode of action of sumatriptan is vascular? A debate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Effect of serotonin in migraine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The control of cranial arteries by humoral mechanisms and its relation to the migraine syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Activation of recombinant h 5-HT1B and h 5-HT1D receptors stably expressed in C6 glioma cells produces increases in Ca2+-dependent K+ current

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Coronary side-effect potential of current and prospective antimigraine drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

5-HT1B receptor polymorphism and clinical response to sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Glycine antagonist and NO synthase inhibitor protect the developing mouse brain against neonatal excitotoxic lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Autoradiographic mapping of [3H]sumatriptan binding in cat brain stem and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Radiofrequency percutaneous Gasserian ganglion lesions. Results in 140 patients with trigeminal pain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Exercise testing in patients with chest pain to sumatriptan.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Characteristics and determinants of sumatriptan-associated chest pain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

[3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Characterization of ligand binding properties of the 5-HT1D receptors cloned from chimpanzee, gorilla and rhesus monkey in comparison with those from the human and guinea pig receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Differentiation of excitatory amino acid receptors in the rat caudal trigeminal nucleus: a microiontophoretic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

5-HT in migraine--an introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The TINS/TiPS Lecture. The molecular biology of mammalian glutamate receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Internal and external carotid vascular responses to vasoactive agents in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Sensitization of meningeal sensory neurons and the origin of headaches

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Controlled thermocoagulation of trigeminal ganglion and rootlets for differential destruction of pain fibers. 1. Trigeminal neuralgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Ergotamine in the acute treatment of migraine: a review and European consensus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Effects of S9977 and dihydroergotamine in an animal experimental model for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Sumatriptan-nonresponders: a survey in 366 migraine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Brain stem activation in spontaneous human migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900010-1

7 January 2021

10.1016/S0301-0082(00)00010-1

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10869781